Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).
A pilot study of a telehealth intervention for persons with spinal cord dysfunction.
Is It Too Early to Predict the Failure of Natalizumab in NMO?
[Vitamin D and neurology.]
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.
Exercise in the management of persons with multiple sclerosis.
Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Subclinical Optic Neuritis in Neuromyelitis Optica.
Pathogenesis of Pediatric Multiple Sclerosis.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop.
Molecular mimicry as a mechanism for food immune reactivities and autoimmunity.
Pages
« first
‹ previous
…
330
331
332
333
334
335
336
337
338
…
next ›
last »